Eargo, Inc. (EAR)
| Market Cap | 54.19M |
| Revenue (ttm) | 41.11M |
| Net Income (ttm) | -108.17M |
| Shares Out | 20.76M |
| EPS (ttm) | 15.02 |
| PE Ratio | 0.17 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 10 |
| Open | 2.62 |
| Previous Close | 2.61 |
| Day's Range | 2.60 - 2.63 |
| 52-Week Range | 1.47 - 16.80 |
| Beta | 1.47 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 7, 2023 |
About EAR
Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. It markets and sells hearing aids. The company sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was incorporated in 2010 and is headquartered in San Jose, California. [Read more]
Financial Performance
In 2022, Eargo's revenue was $37.25 million, an increase of 15.96% compared to the previous year's $32.12 million. Losses were -$157.49 million, -0.17% less than in 2021.
Financial StatementsNews
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Eargo, Inc. and Encourages Investors to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / November 3, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Eargo, Inc. ("...
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Eargo, Inc. and Encourages Investors to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / November 2, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Eargo, Inc. ("...
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Eargo, Inc. and Encourages Investors to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / November 2, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Eargo, Inc. ("...
EARGO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Eargo, Inc. - EAR
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Eargo, Inc. (Nas...
Eargo Celebrates 1-Year Anniversary of FDA's Over-the-Counter (OTC) Hearing Aid Regulations, Driving a New Era of Accessibility and Innovation
SAN JOSE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR) (“Eargo”) celebrates the one-year anniversary of the creation of an over-the-counter (OTC) hearing aid category in the US....
Shareholder Alert: Ademi LLP investigates whether Eargo, Inc. has obtained a Fair Price in its transaction with Patient Square Capital
MILWAUKEE , Oct. 30, 2023 /PRNewswire/ -- Ademi LLP is investigating Eargo (Nasdaq: EAR) for possible breaches of fiduciary duty and other violations of law in its transaction with Patient Square Capi...
EAR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Eargo, Inc. Is Fair to Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Eargo, Inc. (NASDAQ: EAR) to an affiliate of Patient Square Capital for $2.55 per share i...
Eargo Expands Relationship with Best Buy, Growing In-Store Presence to Over 500 Locations
SAN JOSE, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced an expa...
Eargo Reports First Quarter 2023 Financial Results
Recent Highlights: Net revenues of $11.8 million in the first quarter of 2023, up 29% year-over-year Gross systems shipped of 8,705, up 51% year-over-year GAAP total operating loss $22.8 million in th...
Eargo to Report Fourth Quarter 2022 Financial Results on March 23, 2023
SAN JOSE, Calif., March 17, 2023 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve hearing health, today announced it will release financial results for t...
Nasdaq Confirms Eargo's Minimum Bid Price Deficiency is Cured
SAN JOSE, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR) (the “Company” or “Eargo”), a medical device company on a mission to improve the quality of life of people with hearing lo...
Eargo Effects 1-for-20 Reverse Stock Split
SAN JOSE, Calif., Jan. 17, 2023 (GLOBE NEWSWIRE) -- Eargo, Inc. (“Eargo” or the “Company”) (Nasdaq: EAR), a medical device company on a mission to improve the quality of life for people with hearing l...
Eargo to Complete a 1-for-20 Reverse Stock Split
SAN JOSE, Calif., Jan. 11, 2023 (GLOBE NEWSWIRE) -- Eargo, Inc. (“Eargo” or the “Company”) (Nasdaq: EAR), a medical device company on a mission to improve the quality of life for people with hearing l...
NationsBenefits and Eargo Announce Partnership to Offer Over-the-Counter Hearing Aids
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--NationsBenefits®, a leading provider of supplemental benefits, flex cards, and member engagement solutions for health plans, and Eargo, Inc. (Nasdaq: EAR), a ...
Eargo and NationsBenefits Announce Strategic Partnership
NationsBenefits to Sell Eargo Hearing Aids Over-The-Counter (OTC) beginning January 1, 2023 NationsBenefits to Sell Eargo Hearing Aids Over-The-Counter (OTC) beginning January 1, 2023
Eargo Announces Strategic Additions to Board of Directors Following Patient Square Capital Becoming New Majority Shareholder
SAN JOSE, Calif., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (“Eargo” or the “Company”) (Nasdaq: EAR), a medical device company on a mission to improve the quality of life for people with hearing l...
Eargo, Inc. Welcomes Patient Square Capital As New Majority Owner Following Rights Offering
SAN JOSE, Calif., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR) (“Eargo” or “the Company”), a medical device company on a mission to improve the quality of life of people with hearing lo...
Eargo Announces Closing of Rights Offering and Conversion of Patient Square Notes Into Shares of Eargo Common Stock
SAN JOSE, Calif., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (“Eargo” or the “Company”) (NASDAQ: EAR), a medical device company on a mission to improve the quality of life for people with hearing l...
Important Reminder for Eargo Stockholders of Record as of October 24, 2022
DEADLINE TO PARTICIPATE IN EARGO RIGHTS OFFERING IS TOMORROW, NOVEMBER 17, 2022 :
Eargo Announces Issuance of Quarterly Report for Third Fiscal Quarter
SAN JOSE, Calif., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (“Eargo” or the “Company”) (NASDAQ: EAR), a medical device company on a mission to improve the quality of life for people with hearing l...
Eargo to Report Third Quarter 2022 Financial Results on November 3, 2022
SAN JOSE, Calif., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve hearing health, today announced it will release financial results for th...
Eargo Announces Record Date for Proposed Rights Offering
SAN JOSE, Calif., Oct. 13, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (“Eargo” or the “Company”) (NASDAQ: EAR), a medical device company on a mission to improve the quality of life for people with hearing l...
Eargo to Hold Investor Update Conference Call on October 4, 2022
Company to Discuss Recently Commenced Proxy Solicitation Campaign for the 2022 Annual Meeting of Stockholders and the Importance of Voting as Soon as Possible Company to Discuss Recently Commenced Pro...
Eargo Announces Proxy Solicitation for 2022 Annual Meeting; Launch of Proxy Solicitation Web Site
SAN JOSE, Calif., Sept. 20, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (NASDAQ: EAR) (“Eargo”, the “Company,” “we,” or “us”), a medical device company on a mission to improve hearing health, today announced...